Thrive Gum 2 mg - Fast Acting
Natural health product licensed in Canada
- Licence holder
- Haleon Canada ULC
- NPN or DIN-HM
- 80043610
- Status
- Inactive licence
- Licence date
- 15 July 2013
- Revision date
- Not provided
- Form
- Gomme à mâcher
- Route of administration
- Buccale
- Application type
- TPD Cat IV/LS
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Acesulfame Potassium, Maltitol, Dioxyde de titanium, chlorophylline, gomme acacia, Stéarate de magnésium, glycérol, Cire de Carnauba, Menthol, Talc, D-Mannitol, Saveur, Gum base, Dioxyde de silicium, Huile de menthe poivrée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Gomme | minimum: 1 Tous les jours ; maximum: 20 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
To help you stop smoking by reducing withdrawal symptoms and nicotine cravings. Using Thrive Gum enables you to reduce the daily number of cigarettes smoked to ease the transition into a smoke-free lifestyle. Although smoking cessation is preferable, Thrive Gum can also be used in cases when you need to temporarily refrain from smoking, for example, in smoke-free areas, airplanes, etc. or in other situations when you wish to avoid smoking. Clinically proven to reduce cravings twice as fast as Nicotine Polacrilex Gums.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80043610
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.